February 4, 2023


Quotes 5-day view   Delayed Quote. Delayed Hong Kong Stock Exchange





12/13/2022 12/14/2022 12/15/2022 12/16/2022 12/19/2022 Date
8.75(c) 8.13(c) 7.89(c) 8.05(c) 7.39 Last
154 121 029 287 160 382 123 759 665 133 866 946 179 554 960 Volume
-4.48% -7.09% -2.95% +2.03% -8.20% Change

Estimated financial data (e)

Sales 2023 25 445 M
3 650 M
3 650 M
Net income 2023 249 M
35,8 M
35,8 M
Net cash position 2023 11 129 M
1 596 M
1 596 M
P/E ratio 2023 320x
Yield 2023
Sales 2024 31 710 M
4 549 M
4 549 M
Net income 2024 290 M
41,5 M
41,5 M
Net cash position 2024 12 105 M
1 736 M
1 736 M
P/E ratio 2024 6 932x
Yield 2024
Capitalization 97 404 M
13 972 M
13 972 M
EV / Sales 2023 3,39x
EV / Sales 2024 2,69x
Nbr of Employees 1 581
Free-Float 35,3%

Alibaba Health Information Technology Limited is specialized in the direct sale of pharmaceuticals. The turnover is divided across the following activities:

– direct sale of pharmaceuticals (85.2%);

– online sale of pharmaceuticals(12.7%);

– direct healthcare services (1.8%);

– online healthcare services and monitoring of pharmaceuticals (0.3%).

The turnover is divided into the revenue sources of product sales… 

Ratings of Alibaba Health Information Technology Limited

All news about ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED

News in other languages on ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED




ETFs positioned on ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED ETFs and Trackers with Trackinsight




Chart ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED



Duration :


Period :




Alibaba Health Information Technology Limited Technical Analysis Chart | MarketScreener

Technical analysis trends ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED

Short Term Mid-Term Long Term
Trends Bullish Bullish Bullish

Income Statement Evolution

Sell

Buy

Mean consensus OUTPERFORM
Number of Analysts 21
Last Close Price 7,21 CNY
Average target price 6,89 CNY
Spread / Average Target -4,49%